I see this as a very positive aspect.
We can deliver trial data for review to FDA already before our trial has ended!
How many trials do you know where this was proposed by FDA? This could speed up EUA!
This bonus and the relatively short time for trial approval indicates that FDA is very supportive, or they have immense pressure to deliver a wonder drug for COVID